Neonatal Translational Medicine and Technologies

Neonatal Translational Medicine and Technologies

Aim

The translation of fundamental science and engineering into newborn care is crucial if we are to reduce the significant global morbidity and mortality in this population. 

Led by Dr Don Sharkey, the group aims to undertake translational research studies to deliver innovative advances specifically developed for this vulnerable age group.

Ambulance photo-466   
 

Research issue

The 2015 under-5 mortality rate was  approximately 5.9 million children of which 2.7 million (45%) were in the neonatal period (first 28 days of life) with prematurity the leading cause accounting for 1.1 million. In developed countries, newborn survival is improving but subsequent morbidity such as brain injury and chronic lung disease (CLD) remain significant problems.

If we can translate innovative technologies, specifically developed for newborn babies, and undertake neonatal clinical trials addressing major morbidities, such as CLD and brain injury, then children will stand a better chance of growing up and achieving their potential. There are a number of neonatal research domains that are particularly challenging to study, such as medical device development, and so can end up being neglected yet offer significant potential.  We aim to tackle these difficult areas and so address important gaps in clinical care of newborns. 

What we are doing about:

1. Development of neonatal technologies

 

2. Improving neonatal transport

 

3. Newborn resuscitation

 

4. Improving preterm respiratory outcomes

 

Current projects

  1. SurePulse – development of a multi-parameter newborn resuscitation device
  2. Gestation Study – postnatal gestational age assessment using machine learning and computer vision
  3. TRiP Study – developing the next generation neonatal transport system
  4. NeoRate – a novel, App based training tool for newborn resuscitation and vital sign measurement
  5. NeoPredict – utilising artificial intelligence to better manage and recognise respiratory deterioration on the NICU

Outcomes

Relevant key publications

 

 

 

 

 

 

 

 

Neonatal Translational Medicine and Technologies research group

The University of Nottingham
Academic Child Health
East Block, E Floor, QMC
Nottingham, NG7 2UH


telephone: +44 (0) 115 823 0611
email: childhealth@nottingham.ac.uk